
Bleached corals came back to full health in seven weeks.
A brief tissue bridge moved helpful algae within three days—and recovery continued after the corals were separated.
Every serving. No expiration date. Page 2 of 5.

A brief tissue bridge moved helpful algae within three days—and recovery continued after the corals were separated.

The study will test whether clearing amyloid, then adding a second mechanism, can delay inherited Alzheimer's.

A new alliance is coordinating five years of targeted recovery funding.

Reported malaria deaths fell from 3,259 in 2011 to 52 in 2025.

An EMA committee recommended a once-daily oral RAS inhibitor for eligible adults with metastatic pancreatic cancer.

A randomized trial found continuous glucose monitoring added about five hours a day in the target range—even without insulin.

The future changed 2.2 million times.

Eight complete responses. Twelve patients.

Forty-four, from the brink.

A monitor improved when patients could explain what its sensors got wrong.

A 32-person study found less injury and fewer symptoms—but it is still early.

A new WHO review says transmission now remains only in the remote cross-border Yanomami Focus Area shared by Brazil and Venezuela.

In the OPTIMA extension, adults who stayed on Pasatru had no new lesions detected between weeks 56 and 84; the placebo group had nine.

More than 7.86 million people have been screened. Diagnosis reached 92.4%, treatment 92.7%, and treatment in key high-risk groups 95%.

The national average rose above one tonne per hectare in 2025–26; some farmer-field-school groups reached 1.4 to 2 tonnes while cutting pest treatments.

The lower dose met the trial’s main goal over 52 weeks. The higher dose did not, and the detailed results are not yet published.

A preclinical formulation held onto its biological activity for more than two months at 37°C—and matched fresh material in mouse immune-response tests.

The fund starts with $9 million from Walmart Foundation and $9 million in aligned investment from McDonald’s USA and suppliers.

WHO/Europe calls the result an early signal: the evaluation covers five months and independent peer review is pending.

The advocacy-group analysis also found burned areas from 2016–2026 were concentrated in acid grassland, heather, bog and other simplified landscapes rather than restored habitat.

In a 10-person safety trial, an experimental optogenetic treatment produced clinically meaningful light-sensitivity gains in six participants. It did not restore normal sight.

Human lung organoids retained resident T cells, recognized SARS-CoV-2 and responded more strongly after a simulated booster.

Underwater playback helped young corals and fish find experimental reef structures in field trials off Oʻahu.

Three years in, the soil is improving. Full recovery may still take 25 to 50 years.